Subgroup analysis showed that the expression level of CD276 had a significant effect on the prognosis of patients with lung adenocarcinoma, while in patients with squamous cell carcinoma, the expression level had no significant effect on the prognosis. The gene discussed is CD276; the disease is squamous cell carcinoma.